Literature DB >> 3525564

Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes.

F Checler, J P Vincent, P Kitabgi.   

Abstract

A peptidase that cleaved neurotensin at the Pro10-Tyr11 peptide bond, leading to the formation of neurotensin-(1-10) and neurotensin-(11-13), was purified nearly to homogeneity from rat brain synaptic membranes. The enzyme appeared to be monomeric with a molecular weight of about 70,000-75,000 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high pressure liquid chromatography filtration. Isoelectrofocusing indicated a pI of 5.9-6. The purified peptidase could be classified as a neutral metallopeptidase with respect to its sensitivity to pH and metal chelators. Thiol-blocking agents and acidic and serine protease inhibitors had no effect. Studies with specific peptidase inhibitors clearly indicated that the purified enzyme was distinct from enzymes capable of cleaving neurotensin at the Pro10-Tyr11 bond such as proline endopeptidase and endopeptidase 24-11. The enzyme was also distinct from other neurotensin-degrading peptidases such as angiotensin-converting enzyme and a recently purified rat brain soluble metalloendopeptidase. The peptidase displayed a high affinity for neurotensin (Km = 2.6 microM). Studies on its specificity revealed that neurotensin-(9-13) was the shortest neurotensin partial sequence that was able to fully inhibit [3H]neurotensin degradation. Shortening the C-terminal end of the neurotensin molecule as well as substitutions in positions 8, 9, and 11 by D-amino acids strongly decreased the inhibitory potency of neurotensin. Among 20 natural peptides, only angiotensin I and the neurotensin-related peptides (xenopsin and neuromedin N) were found as potent as unlabeled neurotensin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525564

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies.

Authors:  F Checler; H Barelli; J P Vincent
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

3.  Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16.

Authors:  P Dauch; H Barelli; J P Vincent; F Checler
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

4.  Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes.

Authors:  B Vincent; A Beaudet; P Dauch; J P Vincent; F Checler
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

5.  Proteins of the kidney microvillar membrane. Purification and properties of the phosphoramidon-insensitive endopeptidase ('endopeptidase-2') from rat kidney.

Authors:  A J Kenny; J Ingram
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  A Group of Weakly Bound to Neurons Extracellular Metallopeptidases (NEMPs).

Authors:  Ekaterina S Kropotova; Mark I Mosevitsky
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

7.  Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.

Authors:  H Barelli; J E Fox-Threlkeld; V Dive; E E Daniel; J P Vincent; F Checler
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Hydrolysis of rat melanin-concentrating hormone by endopeptidase 24.11 (neutral endopeptidase).

Authors:  F Checler; P Dauch; H Barelli; J L Nahon; J P Vincent
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

9.  Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.

Authors:  H Barelli; V Dive; A Yiotakis; J P Vincent; F Checler
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

10.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

Authors:  P E Millican; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.